Researchers at Carnegie Mellon University, the University of Pittsburgh, and the University of Washington have mapped how 3D genome architecture differs in brain cells affected by Alzheimer’s disease. According to a study published in Science, the research team linked genome folding to gene activity and brain tissue organization using single-cell technology, spatial mapping, and a … Read more
A study of more than 42,000 U.S. death certificates reveals that mortality rates for people with multiple sclerosis (MS) are rising, with significant disparities linked to race, age, and geography. Research published in the journal Neurology indicates that Black patients experience higher mortality rates at younger ages compared to white patients, while cardiovascular conditions like … Read more
A 24-year analysis of 1,712 adults from the Atherosclerosis Risk in Communities (ARIC) study reveals that the impact of sedentary behavior on brain health depends heavily on the activity performed. Research published in the journal Alzheimer’s & Dementia indicates that while television watching is associated with reduced brain volumes and increased vascular markers, occupational sitting … Read more
Neuroscientist Karyn Frick, a professor of psychological and brain sciences at the University of Wisconsin-Milwaukee, is leading research into how estrogens regulate memory, aiming to create new treatments for age-related memory loss and dementia. By studying sex-based differences in neurobiology, Frick’s work seeks to address why middle-aged females often experience more significant memory decline than … Read more
Idiopathic intracranial hypertension (IIH) is a neurological disorder characterized by high pressure within the skull without a tumor or other identifiable cause. Affecting 1 to 20 people per 100,000—most often women of childbearing age—the condition causes narrowing of the venous sinuses and impaired brain fluid circulation. Recent research published in Nature Neuroscience by the Paris … Read more
Researchers at the University of California San Diego and the Rady Children’s Institute for Genomic Medicine have successfully treated two children with SCN2A-related developmental epileptic encephalopathy (DEE) using personalized, allele-selective antisense oligonucleotides (ASOs). According to a study published July 21, 2026, in Nature Medicine, the therapy reduced seizure frequency by up to 90%, improved developmental … Read more
Brain-computer interfaces (BCIs) are shifting from restoring physical movement to treating complex cognitive disorders. According to Dr. Ignacio Saez of the Icahn School of Medicine at Mount Sinai, the next generation of these devices will target conditions like depression, PTSD, and anxiety by functioning as closed-loop systems that detect and regulate dysfunctional brain states in … Read more
Emerging research indicates that immune system dysregulation significantly influences the development of psychiatric disorders, including major depressive disorder (MDD) and schizophrenia. According to findings published in Cells (2025) and Current Opinion in Genetics & Development (2026), while immune signatures—such as elevated C-reactive protein (CRP) and interleukin-6 (IL-6)—are not present in every patient, they appear to … Read more
Negative emotions act as a filter for human memory, forcing the brain to prioritize information relevant to immediate goals while discarding peripheral context. According to a study published in the journal Virtual Reality by researchers at the Universitat Oberta de Catalunya (UOC), this process is a functional adaptation rather than a memory failure. When under … Read more
Researchers have identified the protein Arc as a critical vehicle that transports toxic Tau protein between neurons, potentially driving the progression of Alzheimer’s disease. According to a study published in Cell by investigators at University of Utah Health and Washington University in St. Louis, interrupting this intercellular transport mechanism could offer a new therapeutic strategy … Read more